Literature DB >> 20818924

Aspergillosis: nosocomial or community-acquired?

Marie-Christine Nicolle1, Thomas Benet, Philippe Vanhems.   

Abstract

Discrimination between nosocomial and community infections is important for investigation and prevention. Nosocomial and hospital-acquired infections require appropriate hospital control measures to avert additional cases. Nosocomial infections (NI) occur during hospitalization or are caused by microorganisms acquired during hospital stay. Such infections should not be evident when patients are admitted to the hospital. Furthermore, the definition of NI is based on epidemiological criteria, such as the time lapse between admission and onset, or microbiological criteria. This definition might be difficult to apply to invasive aspergillosis (IA) which often afflicts patients with severe immunosuppression or transplantation. Identification of the source may be difficult which could arise outside or inside the hospital. Another significant issue is the lack of valid and reproducible data on the incubation period. The incubation duration of IA is influenced by different individual or environmental determinants, including the severity of immunosuppression and air quality. The criteria of causality are also a means of discussing the contribution of hospital vs. community determinants of IA. The definition of nosocomial IA remains difficult. A better understanding of early events related to IA onset will help to prevent this disease for which the prognosis remains negative.

Entities:  

Mesh:

Year:  2010        PMID: 20818924     DOI: 10.3109/13693786.2010.509335

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  8 in total

1.  Aspergillus involving submandibular salivary gland: An unusual presentation.

Authors:  Ruchita Tyagi; Pranab Dey
Journal:  J Cytol       Date:  2014-07       Impact factor: 1.000

2.  Monitoring of clinical strains and environmental fungal aerocontamination to prevent invasive aspergillosis infections in hospital during large deconstruction work: a protocol study.

Authors:  Sophie Tiphaine Loeffert; Elise Melloul; Cédric Dananché; Laetitia Hénaff; Thomas Bénet; Pierre Cassier; Damien Dupont; Jacques Guillot; Françoise Botterel; Martine Wallon; Marie-Paule Gustin; Philippe Vanhems
Journal:  BMJ Open       Date:  2017-11-25       Impact factor: 2.692

3.  Efficacy of Gold Nanoparticles against Drug-Resistant Nosocomial Fungal Pathogens and Their Extracellular Enzymes: Resistance Profiling towards Established Antifungal Agents.

Authors:  Abobakr Almansob; Ali H Bahkali; Fuad Ameen
Journal:  Nanomaterials (Basel)       Date:  2022-02-28       Impact factor: 5.076

4.  Antifungal Activity of Select Essential Oils against Candida auris and Their Interactions with Antifungal Drugs.

Authors:  Ryan A Parker; Kyle T Gabriel; Kayla D Graham; Bethany K Butts; Christopher T Cornelison
Journal:  Pathogens       Date:  2022-07-22

Review 5.  Global Aspects of Triazole Resistance in Aspergillus fumigatus with Focus on Latin American Countries.

Authors:  Sarah Santos Gonçalves
Journal:  J Fungi (Basel)       Date:  2017-02-10

6.  Recovery of a triazole-resistant Aspergillus fumigatus in respiratory specimen of COVID-19 patient in ICU - A case report.

Authors:  Théo Ghelfenstein-Ferreira; Anastasia Saade; Alexandre Alanio; Stéphane Bretagne; Raffael Araujo de Castro; Samia Hamane; Elie Azoulay; Swann Bredin; Sarah Dellière
Journal:  Med Mycol Case Rep       Date:  2020-07-02

7.  COVID-19 Associated Pulmonary Aspergillosis (CAPA): Hospital or Home Environment as a Source of Life-Threatening Aspergillus fumigatus Infection?

Authors:  Teresa Peláez-García de la Rasilla; Irene González-Jiménez; Andrea Fernández-Arroyo; Alejandra Roldán; Jose Luis Carretero-Ares; Marta García-Clemente; Mauricio Telenti-Asensio; Emilio García-Prieto; Mar Martínez-Suarez; Fernando Vázquez-Valdés; Santiago Melón-García; Luis Caminal-Montero; Inmaculada Fernández-Simón; Emilia Mellado; María Luisa Sánchez-Núñez
Journal:  J Fungi (Basel)       Date:  2022-03-19

Review 8.  Air pollution and health prevention: A document of reflection.

Authors:  E Bouza; F Vargas; B Alcázar; T Álvarez; A Asensio; G Cruceta; D Gracia; J Guinea; M A Gil; C Linares; P Muñoz; P Pastor; M L Pedro-Botet; X Querol; J Tovar; I Urrutia; F Villar; E Palomo
Journal:  Rev Esp Quimioter       Date:  2022-03-11       Impact factor: 2.515

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.